Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer. (Q113888955)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer. |
clinical trial |
Statements
*Official Title: Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover Bioequivalence Trial of Irinotecan Liposome Injection in Patients With Advanced Pancreatic Cancer. (English)
0 references
7 July 2020
0 references
December 2020
0 references
48
0 references
18 year
0 references